Oncology Institute Of Southern Switzerland
Clinical trials sponsored by Oncology Institute Of Southern Switzerland, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Scientists map immune defenses in ovarian cancer Results expected Dec 2026 (estimated)
- Diet and exercise program tested in men with advanced prostate cancer Results expected Dec 2026 (estimated)
- Could a common antibiotic help fight colorectal cancer? Results expected Dec 2026 (estimated)
- Tumor DNA analysis aims to speed up enrollment in early cancer trials Results expected Dec 2026 (estimated)
- SIESTA study: do cancer hormone treatments steal your sleep? Results expected Dec 2026 (estimated)
-
Prostate cancer immune study pulled before starting
Knowledge-focused CancelledThis study was designed to explore how the drug ruxolitinib affects immune cells inside prostate tumors. Researchers planned to give the drug to men with prostate cancer for 28 days before their scheduled surgery, then analyze tumor and blood samples. However, the study was withd…
Sponsor: Oncology Institute of Southern Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
New model could predict lymphoma progression two years early
Knowledge-focused OngoingThis study aims to create a more accurate tool to predict whether follicular lymphoma patients will remain free of disease progression two years after their first treatment. Researchers will combine clinical information with molecular data from 370 patients to build and test this…
Sponsor: Oncology Institute of Southern Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC